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Cytokines produced during infection/inflammation
activate adaptive central nervous system (CNS)
responses, including acute stress responses medi-
ated by the hypothalamo-pituitary-adrenal (HPA)
axis. The mechanisms by which cytokines engage
HPA control circuitry remain unclear, though stimu-
lated release of prostanoids from neighboring
vascular cells has been implicated in this regard.
How specific vascular cell types, endothelial cells
(ECs) versus perivascular cells (PVCs; a subset of
brain-resident macrophages), participate in this
response remains unsettled. We exploited the
phagocytic activity of PVCs to deplete them in rats
by central injectionof a liposome-encapsulatedproa-
poptotic drug. This manipulation abrogated CNS and
hormonal indices of HPA activation under immune
challenge conditions (interleukin-1) that activated
prostanoid synthesis only in PVCs, while enhancing
these responses to stimuli (lipopolysaccharide) that
engaged prostanoid production by ECs as well.
Thus, PVCs provide both prostanoid-mediated drive
to the HPA axis and an anti-inflammatory action that
constrains endothelial and overall CNS responses
to inflammatory insults.
INTRODUCTION
Episodes of systemic infection or inflammation engage the
innate immune system to release proinflammatory cytokines
that act on the brain to initiate specific central nervous system
(CNS) responses. These include a constellation of acute phase
reactions, including somnolence, fever, lethargy, anorexia, and
metabolic effects (Hart, 1988; Konsman et al., 2002), which facil-
itate adaptation to the challenge at hand. Such insults can also
impact the brain’s intrinsic immune effector mechanisms,94 Neuron 65, 94–106, January 14, 2010 ª2010 Elsevier Inc.notably microglia, to precipitate or exacerbate a host of neuro-
degenerative disorders (Choi et al., 2009; Phillis et al., 2006).
Clarifying the cellular-molecular mechanisms of immune-to-
brain communication thus has implications not only for under-
standing basic central processes involved in coping with acute
illness but also for identifying targets for intervention in neurolog-
ical disease.
Here we focus on one key acute phase response system, the
hypothalamo-pituitary-adrenal (HPA) axis, an integral part of the
brain’s stress response machinery (Turnbull and Rivier, 1999;
van der Meer et al., 1996). Glucocorticoid mediators of HPA
function exert catabolic effects that mobilize energy reserves
to facilitate coping with inflammatory insults and powerfully
suppress immune-inflammatory reactions. This latter effect
plays a critical regulatory role in preventing excess cytokine
production and immune cell proliferation (Webster et al., 2002).
Dysfunction of the central arm of this feedback loop is implicated
in the genesis of autoimmune disorders in susceptible animal
models (Harbuz et al., 1997) and in humans (Wick et al., 1993).
The mechanisms by which immune stimuli impact the brain to
engage the HPA axis remain unsettled. Multiple routes of access
have been supported, whose involvement may vary with the
strength and nature of the insult (Dantzer and Kelley, 2007;
Quan, 2008). For stimuli involving intravenous administration of
individual proinflammatory cytokines (interleukin-1 [IL-1]) or
pathogen analogs (bacterial lipopolysaccharide [LPS]), which
model systemic infection, substantial evidence indicates that
circulating cytokines can be monitored by non-neuronal cells
of the cerebral vasculature, which appear capable of engaging
proximate afferent projections to relevant effector neurons by
releasing local signaling molecules, notably prostaglandin E2
(PGE2; Elmquist et al., 1997; Schiltz and Sawchenko, 2003). In
the case of HPA control circuitry, evidence supports a role for
PGE2 acting on brainstem catecholaminergic neurons that
project to corticotropin-releasing factor (CRF)-expressing hypo-
thalamic neurosecretory cells in initiating IL-1- or LPS-stimulated
drive on the axis (Ericsson et al., 1994, 1997; Schiltz and Saw-
chenko, 2007; van der Meer et al., 1996).
Questions remain as to the manner and extent to which
inducible prostaglandin-dependent mechanismswithin the brain
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type(s) involved in transducing immune signals and mounting
prostanoid responses. Endothelial cells (ECs) of the cerebral
vasculature are optimally positioned to record circulating
immune signals, but their threshold to inducible cyclooxygenase
(COX-2) expression is high (Schiltz and Sawchenko, 2002). Peri-
vascular cells (PVCs), a subset of brain-resident macrophages,
are more sensitive to COX-2 induction (Schiltz and Sawchenko,
2002), but their position in the perivascular space between the
EC basement membrane and the glia limitans (Thomas, 1999;
Williams et al., 2001) makes them unlikely to be accessed
directly by blood-borne cytokines.
To address these issues, we used a method that exploits the
phagocytic capabilities of PVCs to selectively deplete them by
central administration of a liposome-encapsulated drug, clodro-
nate (Polfliet et al., 2001b). The results support a prominent and
selective involvement of brain macrophages and their capacity
to mount prostanoid responses in immune challenge-induced
HPA activation. They also identify a novel, anti-inflammatory
influence of this cell type in restraining endothelial involvement
in CNS host-defense responses to inflammatory insults.RESULTS
Liposome-Mediated Targeting of Brain Macrophages
We sought first to validate a method (Polfliet et al., 2001b) that
exploits the phagocytic activity of PVCs and meningeal macro-
phages (MMs) to selectively deplete them by i.c.v. injection of
liposome-encapsulated clodronate. Clodronate is a bisphospho-
nate drug used to treat osteolytic disease, which can cause
irreversible metabolic damage and apoptosis at high intracellular
concentrations (Van Rooijen and Sanders, 1994). Liposomes
were labeled with the fluorophore DiI to allow visualization of
cells that have incorporated them (Polfliet et al., 2001b). Injection
of control liposomes encapsulating PBS (PBS-Lips) resulted
in selective DiI labeling of meningeal and vascular cells that
expressed the ED2 macrophage differentiation antigen, a defini-
tive PVC/MM marker (Dijkstra et al., 1985; Figure 1). Using clod-
ronate liposomes (Clod-Lips), ED2-positive cells were frankly
reduced in rats sacrificed at 2–3 days and virtually absent in
animals killed 5–7 days after injection.
The effectiveness of liposome-mediated targeting of brain
macrophages was evaluated after each experiment by costain-
ing series of brain sections for ED2, challenge-induced COX-2
expression, and/or the DiI fluorophore. Rats killed 5–7 days after
i.c.v. injection of PBS-Lips and i.v. injection of vehicle displayed
DiI labeling strictly limited to ED2-stained cells associated with
themeninges and cerebral vasculature. The efficiency of labeling
was high, with >95% of all ED2-positive cells colabeled for DiI
in samplings from multiple brain regions (see Experimental
Procedures). COX-2was not detected in DiI- and/or ED2-stained
cells of control animals. In separate series of sections prepared
for concurrent localization of DiI and Iba1, a marker that labels
microglia, as well as PVCs/MMs, we failed to detect DiI labeling
of parenchymal microglia in any experiment (data not shown).
Rats that received i.c.v. injection of control liposomes and
were challenged 7 days later with IL-1 (2 mg/kg, i.v.) displayeda similar disposition of DiI/ED2 labeling, which was overlain by
induced COX-2 expression. Vascular and meningeal COX-2
immunoreactivity was strictly confined to ED2-labeled cells. In
contrast, Clod-Lip-treated animals challenged with IL-1 showed
in most cases a complete absence of vascular and meningeal
labeling for DiI, ED2, and COX-2. In these cases, reliable COX-2
labeling was seen only in neurons (mainly in cortical regions) that
express the enzyme constitutively.
Ancillary analyses were carried out to assess the broader
impact of central liposome treatment. Electron microscopy
(conventional and of ED2-immunolabeled material) of brain
tissue from control and Clod-Lip-treated rats revealed no major
disruption of vascular structure in the latter, save for instances of
vacant areas and/or apparent cellular debris in the perivascular
spaces, presumably reflecting the loss of ED2+ PVCs (Figure 1).
Basal laminae and junctions (zonulae occludens) between
adjoining ECs appeared unaffected, and there was no evidence
of infiltration by circulating lymphocytes. The integrity of the
blood-brain barrier was assessed by injecting experimental
and control animals i.v. with horseradish peroxidase. Light level
analysis of histochemical preparations revealed no detectable
penetration of enzyme into the brain parenchyma in either group,
aside from that expected at circumventricular organs. Finally, as
central injection of Clod-Lips is reported to variably and tran-
siently attenuate peripheral macrophage populations (Polfliet
et al., 2001b), we assessed the most sensitive of these, hepatic
Kupffer cells, during the time window (5–7 days postinjection)
in which immune challenges were administered (Figure S1,
available online). Comparisons of the density of ED2-labeled
cells in comparable series through the liver of control and
Clod-Lip-treated rats (n = 3) revealed no significant difference
(p > 0.1).
These observations support the efficacy and selectivity of
i.c.v. injection of Clod-Lips in depleting brain-resident vascular
and MMs.
Vascular Responses to Immune Insults
Control rats sacrificed 3 hr after IL-1 injection (2 mg/kg, i.v.) dis-
played the expected induction of COX-2 in the cerebral vascula-
ture andmeninges; pretreatment with i.c.v. injection of Clod-Lips
5 days earlier completely eliminated detectable IL-1-induced
COX-2 expression at these loci (Figure 2). LPS injections (2mg/kg,
i.v.) in PBS-Lip rats provoked the expected COX-2 induction in
both multipolar and round vascular profiles shown previously
by dual staining to conform to PVCs (ED2+) and ECs (RECA-
1+), respectively (Schiltz and Sawchenko, 2002). Predictably,
LPS challenges of Clod-Lip pretreated rats elicited COX-2
responsesonly in ECs, but this effectwas remarkably potentiated
in that COX-2-ir ECs were far greater in number (2.4-fold
increase) and staining intensity in macrophage-depleted than
control rats. Because ECs far outnumber PVCs, the overall
density of COX-2-labeled vascular cells in Clod-Lip rats chal-
lenged with LPS more than doubled that of PBS-Lip-pretreated
controls (Figure 2).
Analysis of more specific indices of PGE2 production as func-
tion of treatment status yielded generally compatible findings.
Thus, vascular expression of microsomal prostaglandin E syn-
thase-1 (mPGES-1), a terminal enzyme in PGE2 synthesis, whichNeuron 65, 94–106, January 14, 2010 ª2010 Elsevier Inc. 95
Figure 1. Liposome Targeting of Brain Macrophages
(Top) Fluorescence images showing triple labeling for DiI (left panels, red), ED2 (middle left panels, green), and COX-2 (middle right panel, blue) in the meninges
and a blood vessel of a rat given DiI-labeled PBS-liposomes into a lateral ventricle 7 days prior to an i.v. injection of IL-1 (2 mg/kg). Merged images (right panels)
show that virtually all DiI-labeled profiles colocalize with ED2- and COX-2-irs, indicating that the liposomes were selectively taken up by ED2-positive PVCs and
MMs and that inducible COX-2 expression is discretely localized to this cell type.
(Second row) Images showing the same markers, but from a rat that received i.c.v. injection of clodronate-filled liposomes (Clod-Lips) prior to an IL-1 challenge.
Clod-Lip pretreatment results in a loss of detectable DiI, ED2, and COX-2 labeling in the meninges and blood vessels. Scale bar: 100 mm.
(Third row) Immunoelectron micrographs of arterioles from rats injected i.c.v. with control or Clod-Lips 7 days earlier. Surface labeling for the ED2 antigen (arrow-
heads) is seen in cellular elements displaying macrophage-like features (e.g., numerous lysosomes or multivesicular bodies) in the perivascular spaces (pvs) of
PBS-, but not Clod-Lip-, treated animals. Other aspects of vascular structure, including the morphology of endothelial (EC) and smooth muscle (SM) cells and
basal laminae (bl), are ostensibly unaffected by Clod-Lip treatment. Scale bar: 1 mm.
(Bottom row) Light micrographs through comparable regions of temporal cortex from control and Clod-Lip pretreated rats, showing vascular labeling for HRP
60 min after i.v. injection. No evidence of leakage of enzyme into brain parenchyma is evident. Scale bar: 100 mm.
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under basal conditions, but was mildly upregulated in response
to IL-1 andmore strongly in response to LPS in control (PBS-Lip)
rats (Figure S2). Concurrent dual localization ofmPGES-1mRNA
and ED2-ir indicated that enzyme expression included PVCs
in both challenge paradigms, though these were sparse.96 Neuron 65, 94–106, January 14, 2010 ª2010 Elsevier Inc.Clod-Lip pretreated animals displayed massively potentiated
upregulation of mPGES-1 mRNA in presumed ECs following an
LPS challenge, consistent with the COX-2 findings in this cell
type described above, but this was also seen in IL-1-injected
rats, whose endothelia failed to mount a detectable COX-2
response.
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biosynthetic enzymes in Clod-Lip pretreated rats is reflected
in altered release of PGE2, we attempted time course analyses
in which prostanoid levels were measured by enzyme immuno-
assay in extracts of hypothalamus or medulla. This was not
feasible in IL-1-challenged animals, as basal and stimulated
PGE2 were below the detection limits of the assay. With LPS,
however, Clod-Lip pretreated rats displayed a more rapid,
pronounced, and prolonged LPS-induced rise in brain tissue
levels of PGE2 than controls (Figure 2). To overcome the lack
of sensitivity in the IL-1 model, we established a protocol for im-
munolocalization of PGE2 itself (see Experimental Procedures)
and found a clear and discrete upregulation of PGE2-ir in identi-
fied PVCs of intact rats injected with IL-1; similarly challenged
Clod-Lip pretreated animals failed to display detectable prosta-
noid signals in brain (Figures 2 and S3). LPS challenge in control
rats also gave rise to detectable PGE2 immunostaining, which
was punctate in appearance and codistributed in part with an
endothelial marker. This staining was enhanced in macro-
phage-depleted rats and, in addition, extended into the paren-
chyma, with some taking the form of microglial-like cellular
profiles, a localization confirmed by costaining with a microglial
marker (Iba-1; data not shown).
Overall, the enhanced inducible PGE2 responses to LPS in the
brain macrophage-depleted model indicates that PVCs exert
a potent restraining influence on EC activity in transducing circu-
lating immune signals. The starkly differential effects of liposome
treatment on multiple indices of PGE2 production after IL-1
versus LPS challenges define models for evaluating the role of
vascular prostanoid synthesis in acute phase responses.
Effects on Central Stress-Related Circuitry
Differences in IL-1- and LPS-induced vascular COX-2 induction
in Clod-Lip animals were mirrored in challenge effects on HPA
control circuitry, assessed using Fos immunostaining as a
generic marker of cellular activation (Figure 3). Projections to
thehypothalamusarising fromcatecholamine-containing (adren-
ergic and noradrenergic) neurons in the caudal brainstem
(nucleus of the solitary tract and ventrolateral medulla) have
been specifically implicated in mediating IL-1 and LPS effects
on HPA output (Ericsson et al., 1994; Schiltz and Sawchenko,
2007; van der Meer et al., 1996). Here, we confirmed that
both cell groups display markedly increased Fos expression
in response to standard doses of IL-1 or LPS (2 mg/kg, i.v.).
Costaining for Fos and the catecholamine biosynthetic enzymes
dopamine-b-hydroxylase and phenylethanolamine-N-methyl-
transferase identified the overwhelming majority of responsive
neurons as displaying the adrenergic or noradrenergic pheno-
type (Figure S4). Whereas Clod-Lip pretreatment exerted no
discernible effect on Fos expression in saline-injected controls,
it resulted in markedly reduced responses to IL-1, to levels that
did not differ reliably from those of controls. In contrast, brain
macrophage depletion yielded significant increases in the
number of NTS and VLM neurons displaying activational
responses to LPS, over and above that seen after similar injection
in PBS-Lip pretreated animals (p < 0.01).
At the level of hypothalamic effectors that control HPA output,
IL-1-induced Fos expression in control rats was focused in theCRF-rich hypophysiotropic zone of the PVH, and this response
was reduced (by 80%) in Clod-Lip pretreated animals to levels
that did not differ from those of vehicle-injected control animals
(p > 0.1). LPS provoked a similarly focused, but more robust,
activation of PVH neurons in PBS-Lip rats. Clod-Lip pretreat-
ment resulted in a reliable increase in the number of responsive
PVH neurons, attributable to recruitment of cells in the magno-
cellular division of the nucleus, which have also been implicated
as contributing to central drive on the HPA axis (Holmes et al.,
1986). This analysis was carried out in material prepared under
staining conditions that optimize sensitivity of immunolocaliza-
tion, and the robustness of LPS-induced Fos in the parvocellular
neurosecretory zone of the PVH might impose a ceiling effect.
Staining of additional series of sections from control and Clod-
Lip animals challenged with LPS using higher dilutions of Fos
antiserum revealed a reliable (31%) increase in the number of
labeled cells in the parvocellular PVH, supporting the contention
that macrophage depletion results in enhanced drive to both
major functional compartments of the nucleus. This finding
was further supported by comparisons of relative levels of CRF
mRNA in the PVH, which revealed a reliably greater increase in
the Clod-Lip (2.2-fold) than PBS-Lip group (1.6-fold) in response
to LPS (p < 0.05).
Together, these findings indicate that brain macrophages are
required for IL-1 engagement of HPA control circuitry, which at
bothmedullary andhypothalamic levels responds tobrainmacro-
phage depletion in a manner indicative of a positive relationship
with vascular COX-2/PGE2 production. This extends to the
exaggerated HPA-regulatory responses seen in the LPS model.
Stress Hormone Secretion
To determine whether altered responsiveness of HPA control
circuitry as a function of brain macrophage status is mirrored
by changes in hormonal output, separate groups of rats (n = 5)
pretreated with control or Clod-Lips were implanted with jugular
catheters and challenged 2 days later with IL-1 or LPS as
above, and repeated blood samples were collected for radioim-
munoassay of plasma adrenocorticotropic hormone (ACTH)
and corticosterone. Basal titers of neither hormone varied
reliably as a function of brain macrophage status (Ps > 0.1;
Figure 4). An IL-1 challenge elicited rapid and reliable increases
in plasma levels of both hormones that peaked at similar time
points. However, both the ACTH and corticosterone secretory
responses of Clod-Lip-treated rats were of significantly lesser
magnitude and duration than those of control animals. Total inte-
grated responses, as assessed by calculating areas under the
curve (AUC), were reduced to 49% (ACTH) and 37% (corticoste-
rone) of control values (Ps < 0.001).
LPS also elicited significant increases in ACTH and corticoste-
rone secretion in both groups that peaked at similar time points,
and in the case of corticosterone achieved similar maxima
(Figure 4). But the magnitude of peak ACTH titers and the dura-
tion of both hormonal responses were substantially greater in
Clod-Lip-treated rats, as were AUC measures (2.4- and 1.5-fold
increases forACTHandcorticosterone, respectively; Ps<0.001).
Thus, the differential effects of brain macrophage depletion on
IL-1- and LPS-driven engagement of HPA control circuitry are
predictive of alterations in stress hormone secretion.Neuron 65, 94–106, January 14, 2010 ª2010 Elsevier Inc. 97
Figure 2. Liposome Effects on Indices of Vascular Prostanoid Production
(Top) Differential effects of liposome treatment on induced vascular COX-2 induction. IL-1 treatment in control (PBS-Lip) animals induces COX-2 in multipolar
cells (shown previously to correspond to PVCs), while LPS activates the enzyme in both PVCs (arrows) and in round profiles that conform to nuclear/perinuclear
regions of endothelia. While Clod-Lip treatment eliminates IL-1-induced COX-2 expression by ablating PVCs, it enhances LPS effects on the number and
staining intensity of COX-2-ir in endothelia, indicating that PVCs restrain EC responsiveness. Histogram shows quantitative comparison of the density (number
of cells/mm2 vascular area) of COX-2-ir PVCs, endothelia, and total vascular cells as a function of treatment status. n = 6 per group. *p < 0.001 versus PBS-
liposome-treated controls.
(Middle) LPS effects on tissue PGE2 levels in control and Clod-Lip pretreated rats. LPS-induced elevations in mean (±SEM) PGE2 concentration in medulla are
significantly greater over 1–3 hr after injection in brain macrophage-deficient rats.
(Bottom) Effects of brain macrophage depletion on immune challenge-induced PGE2-ir in vascular cell types. Merged confocal images from rats treated with IL-1
(top row) or LPS (bottom row) co-stained for PGE2-ir (green) markers (red) for perivascular (ED2; top) or EC (RECA-1; bottom) in untreated (left) and IL-1- or LPS-
challenged rats pretreated with control (middle) or clodronate liposomes (right). Doubly stained elements appear as yellow. Under control conditions, PGE2-ir is
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Groups of rats (n = 9) pretreated centrally with clodronate or
control liposomes were implanted with telemetry transducers
to allow continuous remote monitoring of body temperature
and locomotor activity. Two days later, they were challenged
with IL-1 or LPS 1 hr prior to the onset of the nocturnal phase
of the lighting cycle, when animals are most active.
In rats pretreated with control liposomes, IL-1 elicited
a biphasic core temperature response, with an initial mild hypo-
thermia preceding a more substantial fever that peaked at 2 hr
after injection (Figure 5). Clod-Lip treated animals failed to exhibit
a significant decline in core temperature, but the peakmagnitude
of their febrile responses did not differ reliably from those of
controls. LPS provoked in both groups an early rise and decline
in core temperature, whose timing and magnitude were similar.
Thereafter, controls exhibited a biphasic rise in temperature
with peaks at roughly 2.75 and 6 hr after injection, whereas brain
macrophage-depleted rats displayed a monophasic fever that
peaked at 6 hr and whose magnitude was significantly greater
over the 3.5–4.5 hr time interval (Ps < 0.05).
In contrast, activity responses were unaffected by Clod-Lip
pretreatment. Both IL-1 and LPS treatments (Figure 5) gave
rise to rapid and significant (Ps < 0.01) decrements in activity
beginning at 0.5–1.5 hr after injection, and their magnitude did
not differ reliably as a function of brain macrophage status at
any time point through 6 hr after injection (Ps > 0.10; Figure 5).
Repetition of this study in separate groups challenged with
IL-1 or LPS during the subjective morning hours yielded compat-
ible results (Figure S5).
DISCUSSION
Differential effects of brain macrophage ablation on indices of
cerebrovascular PGE2 production induced by IL-1 (reduced)
versus LPS (exaggerated) were paralleled by altered responses
of the HPA axis and its CNS control circuitry. Other acute phase
responses were affected less profoundly (fever) or not at all (leth-
argy). The results support a dependence of HPA responses to
proinflammatory insults on the integrity of PVCs and their
capacity to mount prostanoid responses and define a novel
anti-inflammatory interaction between perivascular cells and
ECs in transducing circulating cytokine signals and sculpting
specific CNS responses to them.
Model and Implications
A model to summarize these findings is provided in Figure 6. In
response to IL-1, the circulating cytokine activates PVCs most
likely indirectly, after first being bound by endothelial type 1
IL-1 receptors (Ericsson et al., 1995). ECs are responsive to
this stimulus and signaling through them is required for upstream
CNS effects (Ching et al., 2007; Gosselin and Rivest, 2008), but
they do not display detectable indices of PGE2 production, due
at least partly to a restraining influence exerted on them by
PVCs. PVC activation leads to production and release of PGE2,not detectable in either vascular cell type. In intact rats, IL-1 provokes robust cy
labeling is absent in PVC-depleted animals. LPS induces more widespread punct
in Clod-Lip-pretreated animals. Scale bars: 100 mm.which acts in a paracrinemanner to engage HPA control circuitry
and, consequently, its effector arm in the endocrine hypothal-
amus. Accordingly, elimination of PVCs abrogates vascular
PGE2 production and theHPA response.Moderate to high doses
of LPS engage PVCs in a similar manner and are able to
partially overcome the PVC-imposed brake, leading to endothe-
lial PGE2 synthesis and a greater total vascular prostanoid
response. PVC ablation removes the brake, leading to further
enhancement of EC and overall PGE2 production, and its effects
are manifest particularly during the later stages of HPA and
febrile responses.
The immune challenge parameters used here were chosen
based on their ability to elicit vascular COX-2 responses exclu-
sively from PVCs (IL-1) or from both these and ECs (LPS; Schiltz
and Sawchenko, 2002). Bolus administration of IL-1 is an admit-
tedly artificial situation, but presents a discrete stimulus that
mimics many CNS effects of systemic infection (Dinarello,
1991). LPS is a component of the cell wall of gram-negative
bacteria and is widely used to model infection or sepsis (Ulevitch
and Tobias, 1995). It stimulates the release of several proinflam-
matory cytokines, prominently including IL-1 (Turnbull and Riv-
ier, 1999), and can also act directly by binding a toll-like receptor
4/MD2/CD14 complex (Laflamme and Rivest, 2001). Impor-
tantly, like IL-1, low doses of LPS stimulate COX-2 only in
PVCs (Schiltz and Sawchenko, 2002) and we would predict
that results obtained in the IL-1 model would generalize to mild
LPS challenges.
These findings clarify the cellular mechanisms by which chal-
lenges that model systemic infection access the brain to engage
specific CNS response systems, notably HPA axis activation and
fever, that facilitate coping with insult. Glucocorticoid mediators
of HPA function serve to mobilize energy reserves and constrain
systemic immune responses, while fever may create a subop-
timal thermal environment for pathogen proliferation and can
directly enhance certain host defense mechanisms (Mackowiak,
1998).
Understanding the transit of immune signals across the blood-
brain barrier also has implications for the many neurodegenera-
tive diseases in which central inflammatory mechanisms are
believed to play a contributing role. Systemic LPS and/or IL-1
treatment is commonly reported to exacerbate neuropathology
and cognitive/behavioral symptoms in animal models of
Alzheimer’s, Parkinson’s and Prion diseases and ALS (Byler
et al., 2009; Cunningham et al., 2005; Kitazawa et al., 2005;
Letiembre et al., 2009). A single (high) dose of LPS, alone, can
cause persistent CNS inflammation and neuronal loss (Qin
et al., 2007). Moreover, animals challenged neonatally with IL-1
or LPS display altered central regulation of the HPA axis that
persists into adulthood (Shanks et al., 1995) andmay predispose
individuals to an even broader array of stress-related patholo-
gies. In this light, the identification of a potent anti-inflammatory
mechanism at the blood-brain interface should provide leverage
in identifying targets for intervention in a range of pathologies.
The liposome-targeting approach used here has been showntoplasmic PGE2 staining localized discretely to PVCs, while cytokine-induced
ate PGE2 staining, a portion of which localizes to ECs; this labeling is enhanced
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Figure 3. Liposome Effects on Immune Challenge-Induced Activation of HPA Control Circuitry
Brightfield images of IL-1- and LPS-induced Fos expression in the ventrolateral medulla (top) and PVH (middle) as a function of brain macrophage status. Histo-
grams showmean ±SEMnumber of cells in the A1 andC1 regions of the ventrolateral medulla and PVH in each condition (n = 5–7 per group). Liposome treatment
did not significantly affect basal levels of Fos expression in either region, and data from PBS- and Clod-Lip rats that received i.v. saline injections are pooled for
presentation. Clod-Lip treatment reduced IL-1 stimulated Fos expression in medullary neurons whose projections are required for HPA activation and their hypo-
thalamic targets in the parvocellular part of PVH (mp; outlined in blue) that governs HPA output. In contrast, brain macrophage depletion enhanced activational
responses induced by LPS at both levels of the HPA control circuit. This includes recruitment of additional cell types in the magnocellular division of the nucleus
(pm; outlined in red).
(Bottom) Darkfield photomicrographs showing CRF mRNA under basal (saline-injected) and 3 hr after LPS challenge in control and Clod-Lip-injected rats.
Mean ± SEM relative levels of this transcript in these treatment groups (n = 5–8) are shown. Clod-Lip pretreated rats display significantly enhanced upregulation
of CRF mRNA, relative to similarly challenged rats that received control liposome injections. *p < 0.05; **p < 0.01 versus saline-injected controls. Scale bars:
100 mm.
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Figure 4. Liposome Effects on Challenge-
Induced Stress Hormone Secretion
Mean ± SEM plasma ACTH (top) and corticoste-
rone (CORT; bottom) levels in control rats (black)
and animals pretreated with Clod-Lips (red) and
subsequently challenged with i.v. injection of
3 mg/kg IL-1 (left) or 2 mg/kg LPS (right). In IL-1-
challenged rats, macrophage ablation did not
affect the timing of peak ACTH and CORT
responses, but attenuated their magnitude, and
markedly reduced the time over which significant
elevations were observed. Conversely, and in
line with the COX-2 and Fos data, the principal
effect of Clod-Lip pretreatment in LPS-challenged
rats was to significantly enhance the longevity of
hormonal responses. n = 5–6 per group. *, differs
significantly from control liposome group,
p < 0.05; **p < 0.01; ***p < 0.001.
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sclerosis, meningitis, and Alzheimer’s disease (Hawkes and
McLaurin, 2009; Polfliet et al., 2001a, 2002) and the feasibility
of using the stem cells that give rise to them as vehicles for
gene therapy has been established (Hahn et al., 1998; Priller
et al., 2001).
What Are Perivascular Cells?
Along with MMs, PVCs are derived from bone marrow precur-
sors that populate the brain in early postnatal life and turn over
slowly throughout adulthood (Bechmann et al., 2001a; Vallieres
and Sawchenko, 2003). They are distinct from pericytes and
parenchymal microglia, though they may share a common
lineage with them (Gehrmann et al., 1995; Thomas, 1999). As
shown in the present study, PVCs are constitutively phagocytic,
with their definitive ED2 marker having been identified as a
macrophage scavenger receptor, CD163 (Fabriek et al., 2007).
PVCs can serve as antigen-presenting cells (Hickey and Kimura,
1988), participate in the immune surveillance of the nervous
system (Bechmann et al., 2001b; Hickey, 2001), and have been
implicated in a host of pathological processes, including the
entry of HIV into the nervous system (Stoll and Jander, 1999;
Thomas, 1999).
Prostaglandin Involvement in CNS Host Defense
PGE2 levels in brain are increased following systemic IL-1 or LPS
injection (Dinarello, 1991; Sehic et al., 1996), and a wealth of
evidence indicates that central or peripheral blockade of prosta-
noid synthesis using COX inhibitors (NSAIDs) can disrupt the
HPA activation normally elicited by these challenges (Ericsson
et al., 1997; Katsuura et al., 1988; Lacroix and Rivest, 1998;Neuron 65, 94–106Watanabe et al., 1990). The cellular sour-
ces of central prostaglandin production
have remained a major point of conten-
tion, with previous reports being divided
as to whether PVCs (Elmquist et al.,
1997; Schiltz and Sawchenko, 2002) or
ECs (Cao et al., 1996; Matsumura et al.,1998; Quan et al., 1998) are the dominant seats of LPS- and/or
IL-1-driven vascular COX-2 induction. We offered a potential
reconciliation by identifying PVCs as the sole site of COX-2
expression following IL-1 or low doses of LPS, with endothelia
recruited at higher endotoxin doses (Schiltz and Sawchenko,
2002).
Multiple indices of IL-1-driven HPA activity were suppressed
in brain macrophage-depleted rats, supporting a prominent
role for PVCs in the activation of central stress circuitry and
hormone secretion under this condition. As IL-1 is the most
potent of the proinflammatory cytokines induced by LPS in stim-
ulating HPA output (Turnbull and Rivier, 1999), we conclude that
PVCs provide a generalized, low-threshold impetus for the
engagement of this system by infection/inflammation. Hormonal
responses to IL-1 were not completely eliminated by central
macrophage depletion, leaving open possible contributions of
adjunct central or peripheral mechanisms. Direct IL-1 actions
on the pituitary and adrenal glands to stimulate ACTH and corti-
costerone secretion, respectively, have been described (Bernton
et al., 1987; Engstrom et al., 2008).
In addition to indicating a requirement for PVCs in IL-1-induced
HPAactivation, our findings are also consistentwithCOX-depen-
dent PGE2 production in mediating this influence. PGE2 produc-
tion from the COX-dependent intermediate PGH2 may be
catalyzed by several terminal PGE2 synthases, with mPGES-1
being commonly coupled to COX-2 activity (Ivanov and Roma-
novsky, 2004). While we found that vascular mPGES-1 expres-
sion co-varied directly with COX-2, PGE2, and HPA-related
endpoints across most treatment conditions, it was expressed
only weakly in PVCs of IL-1-stimulated rats. This raises the ques-
tion of how PGE2 is generated in this cell type with the alacrity, January 14, 2010 ª2010 Elsevier Inc. 101
Figure 5. Liposome Effects on IL-1- and
LPS-Induced Fever and Lethargy
(Left) Mean ± SEM change in core body tempera-
ture (Tc; data points in 3min bins) of rats pretreated
with control (black) or Clod-Lips (red) and chal-
lenged (arrowhead) with i.v. injection of IL-1 (top)
or LPS (bottom) 1 hr before lights out. Brainmacro-
phage ablation eliminated an early hypothermic
response to IL-1, but did not significantly affect
the magnitude or duration of subsequent fever. In
contrast, LPS-induced fever was enhanced at
3.5–4.5 hr after injection.
(Right) Locomotor activity data (averaged into
30minbins) from the sameanimals.Clod-Lip treat-
ment did not affect the hypoactivity elicited by
either treatment. n = 9 per group. *, differs signifi-
cantly from control liposome group, p < 0.05.
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Vascular Mediation of Inflammatory Effects on CNSrequired of acute phase mechanisms. There are recent data to
implicate the constitutively expressed cyclooxygenase isoform
COX-1 in the initial phase of LPS-induced HPA activation
(Elander et al., 2009; Garcia-Bueno et al., 2009; Zhang et al.,
2003). New findings that COX-1 is expressed under basal
conditions by PVCs and microglia, and is LPS-inducible in
endothelia (Garcia-Bueno et al., 2009), are consistent with a
role in the present context. It remains to be determined whether
other PGE2 synthases, notably COX-1-associated cytosolic
PGES, are positioned to support COX-1 involvement.102 Neuron 65, 94–106, January 14, 2010 ª2010 Elsevier Inc.Involvement of PGE2, itself, in CNS
responses to inflammatory stimuli is
commonly inferred on the basis of COX-
2 expression. Here, we provide bio-
chemical/histochemical data supporting
discrete PGE2 induction in PVCs after
IL-1 treatment, more broadly in response
to LPS, and for regulation in step with
HPA endpoints in macrophage-depletedrats. This evidence is correlative, and it must be noted that
PGE2 is one of several prostanoids whose levels increase in brain
following insults of the kind we used (Choi et al., 2008; de Vries
et al., 1995). Supporting specific involvement of PGE2 are the
findings that IL-1 activatesmedullary catecholaminergic neurons
that express EP3 (and inducible EP4) PGE2 receptors (Ek et al.,
2000) and that microinjection of PGE2 into these cell groups
discretely activates them and their hypothalamic targets that
govern HPA output in a manner closely mimicking the response
to systemic immune challenge (Ericsson et al., 1997). In addition,Figure 6. Cellular Mechanisms for
Engaging HPA Control Circuitry by IL-1 or
LPS Challenges
(Top) Reprise of the core circuitry required for acti-
vation of the HPA axis, highlighting projections
from medullary adrenergic and noradrenergic
(blue and red arrows) cell groups to CRF-express-
ing neurosecretory neurons in the PVH.
(Bottom) Vascular mechanisms for transducing
circulating cytokine signals, involving initial moni-
toring by ECs with consequent activation of
PGE2 synthesis/release (green dots) by PVCs
under IL-1 treatment (left) and by both perivascular
and ECs under the more complex stimulus
presented by LPS (right). Factor(s) produced by
PVCs restrain (red arrow) endothelial responsive-
ness under basal and challenge conditions.
Paracrine mediators of bidirectional interactions
between the two cell types remain to be identified.
Neuron
Vascular Mediation of Inflammatory Effects on CNSgenetic deletion of PGE2 receptor subtypes (EP1 and EP3) atten-
uates HPA responses to LPS (Matsuoka et al., 2003).
Response Specificity of PVC Involvement
The disruptive effect of brain macrophage depletion on IL-1-
induced HPA activation did not generalize to other acute phase
responses. The body temperature profile was not affected, save
for an attenuation of an early hypothermic response. In contrast,
later phases of LPS-induced fever (stages 2–3 in the terminology
of Romanovsky et al. [2005]) were enhanced. The timing of this
effect correlates well with observed elevations in endothelial
COX-2, mPGES-1 expression, and PGE2 levels in Clod-Lip-
treated rats, again reflecting PVC-imposed restraint of endothe-
lial PGE2 production. Our failure to detect any effect of brain
macrophage depletion on IL-1- or LPS-induced reductions in
locomotor activity is consistent with reports that COX inhibitors
affect this response subtly, if at all (Otterness et al., 1991; Wiec-
zorek and Dunn, 2006). Overall, the results indicate differential
involvement of the mechanisms we describe in acute phase
responses.
Perivascular-Endothelial Cell Interactions
The shift in the EC COX-2/PGE2 production that we describe
following ablation of an adjacent cell type (PVCs) has an
intriguing parallel in recent work on cardiac myocytes and fibro-
blasts (Wang et al., 2009). In the present case, the throttling
influence of PVCs is also evident using more generic markers
of EC activation, including the vascular early response gene
Verge and components of the nuclear factor-kB signaling
pathway (J.S. and P.E.S., unpublished data). In view of the
potential for exploiting this mechanism to intervene in inflamma-
tory CNS disease, its molecular underpinnings are of particular
interest. One candidate for fulfilling such a role is nitric oxide;
its expression can be induced by LPS or IL-1 in a number of
tissue macrophage populations and cerebrovascular elements
(Wong et al., 1996a, 1996b) and it can inhibit cytokine-stimulated
endothelial COX-2 expression (Blais and Rivest, 2001), as well as
HPA activation (Turnbull and Rivier, 1999). Another potential
mediator is 15-deoxy D12,14 prostaglandin J2 (15d-PGJ2), an
alternate COX-dependent prostanoid product. 15d-PGJ2 has
been shown capable of suppressing LPS-induced COX-2
synthesis by serving as an endogenous ligand for the peroxi-
some proliferator-activated receptor-g (PPARg) and/or by direct
interference with nuclear factor-kB signaling pathway, both of
which are present and active in the vascular endothelium (Bian-
chi et al., 2005; Inoue et al., 2000; Simonin et al., 2002). Inhibitory
effects of 15d-PGJ2 on LPS-induced fever have been described
(Mouihate et al., 2004), though it remains unclear whether this or
other PPARg ligands are produced in meaningful concentrations
in the cellular context of interest here.
Concluding Remarks
The results indicate dual, time-dependent roles of brain resident
macrophages in CNS responses to inflammatory insults. These
cells are required for full manifestation of HPA responses to
IL-1 challenge, and this requirement exhibits acute phase
response specificity. This same cell type serves normally to
restrain endothelial prostanoid production; in its absence, thelatter stages of HPA and febrile responses to LPS are enhanced.
Across conditions, HPA and febrile responses co-varied closely
with overall vascular COX-2/PGE2 expression, supporting a
dynamic, prostanoid-based transduction mechanism at the
brain-vascular interface. Further elaboration of this interplay is
expected to clarify central mechanisms of adaptation to acute
sickness and to provide leverage in the many CNS disease
states in which inflammatory mechanisms are involved.
EXPERIMENTAL PROCEDURES
Animals
Adult male Sprague-Dawley albino rats (260–340 g) were housed under stan-
dard vivariumconditionswith food andwater freely available andwere adapted
tohandling for at least 5daysprior tomanipulation.All protocolswere approved
by the Institutional Animal Care and Use Committee of the Salk Institute.
Liposome Preparation and Delivery
Liposomes were prepared as previously described (Van Rooijen and Sanders,
1994). These are polylamellar phosphatidylcholine-cholesterol membranes
that encapsulate clodronate (used at a concentration of 250 mg/ml), are man-
nosylated to facilitate receptor-mediated uptake, and are labeled with carbo-
cyanine dye DiI (D282; Molecular Probes) to enable detection of cells that have
incorporated them. For i.c.v. injection, rats were anesthetized with ketamine-
xylazine-acepromazine (25:5:1 mg/kg, s.c.) and mounted in a stereotaxic
frame. Control (encapsulating PBS) or clodronate-liposomeswere equilibrated
to room temperature, gently shaken to resuspend them, and injected in
a volume of 50 ml over 10 min into a lateral ventricle using a 26 gauge needle
mounted onto a stereotaxic arm and attached via PE tubing to a 1000 ml
gastight syringe (Bee Stinger, BAS). Rats were allowed 5–7 days to recover
prior to testing, the point at which depletion of brain macrophages is maximal,
and prior to repopulation by bone marrow-derived progenitors (Polfliet et al.,
2001b; Van Rooijen and Sanders, 1994).
Intravenous Administration of IL-1b and LPS
Indwelling jugular catheters (PE 50) containing sterile, heparin-saline (50 U/ml)
were implanted under isoflurane anesthesia (Ericsson et al., 1994). After 2 days
recovery, awake and freely moving rats were injected with 2 mg/kg of recombi-
nant rat IL-1b (provided by R. Hart, Rutgers University) or its vehicle (1 ml/kg,
0.01% BSA, 0.01% ascorbic acid, 10 mM Tris-HCl, and 36 mM sodium phos-
phate buffer [pH 7.4]) and returned to their home cages. In similar experiments,
groups of rats were injected with LPS from E. coli at 2.0 mg/kg (Sigma-Aldrich;
serotype 055:B5) or sterile saline (1 ml/kg).
Perfusion and Histology
At appropriate time points (2–4 hr after injection), rats were anesthetized and
perfused via the ascending aorta with 4% paraformaldehyde in borate buffer
(pH 8.0) at 4C and the brains were removed, postfixed for 3 hr, and cryopro-
tected overnight. Regularly spaced series of coronal sections (30 mm thick)
were collected in cryoprotectant solution and stored at20Cuntil processing.
Immunohistochemistry
Immunolocalization was achieved using conventional avidin-biotin immuno-
peroxidase (Vectastain Elite kit; Vector Laboratories) and dual indirect immu-
nofluorescence methods (Sawchenko et al., 1990), the latter employing fluo-
rescein-, Cy5-, and/or Alexa 488-conjugated secondary antisera (Molecular
Probes). Combined immunoperoxidase staining with dual fluorescence or
with in situ hybridization was carried out using protocols described previously
(Chan et al., 1993; Ericsson et al., 1994).
Descriptions of all but one of the antisera used are provided as Supple-
mental Experimental Procedures. To localize PGE2-ir, a rabbit polyclonal anti-
serum raised against PGE2 (Oxford Biomedical Research) was used. This
serum recognizes PGE2 and associated pathway-specific arachidonate deriv-
atives, including PGE1, PGA2, and PGB2, but does not cross-react with other
prostanoids. After screening a range of fixation protocols in sections from ratNeuron 65, 94–106, January 14, 2010 ª2010 Elsevier Inc. 103
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Vascular Mediation of Inflammatory Effects on CNStissues that express PGE2 constitutively (kidney and gut) and the brains of IL-1-
or LPS-treated animals, the following yielded the most sensitive and discrete
localization in the cerebral vasculature. Rats were rapidly anesthetized and
perfused briefly via the ascending aorta with saline (100 ml over 2 min).
Brains were then extracted, immersed in ice-cold saline for 1 min, and trans-
ected in the coronal plane into forebrain and brainstem blocks, and immersion
fixed overnight in 4% paraformaldehyde in borate buffer (pH 9.5) with 15%
sucrose added. Adsorption tests were carried out by incubating antiserum
overnight in the presence of graded concentrations of PGE2 (half order of
magnitude increments between 2.8 mM and 2.8 mM) prior to application to
brain sections from IL-1- or LPS-challenged rats. Concentrations R280 mM
abolished all detectable labeling.
Hybridization Histochemistry
Techniques for probe synthesis, hybridization, and autoradiographic localiza-
tion of mRNA signal were adapted from Simmons et al. (1989) and are detailed
as Supplemental Experimental Procedures.
Electron Microscopy
These procedures are described as Supplemental Experimental Procedures.
Intravenous HRP Injections
This procedure is described as Supplemental Experimental Procedures.
Stress Hormone Assays
Separate groups of animals were implanted with indwelling jugular catheters
5 days after i.c.v. injection of clodronate or control liposomes and 2days before
stress exposure. Blood samples (300 ml) were taken prior to i.v. injection of IL-1
or LPSat30minand thenhourly through6hrafter injection. Theywerecollected
into chilled EDTA-containing tubes and centrifuged; plasma was stored at
20C until assay. ACTH was measured using a two-site immunoradiometric
assay obtained in kit form (DiaSorin), with intra- and inter-assay coefficients
of variation of 3% and 9%, respectively, and a sensitivity of 5 pg/ml. Plasma
corticosterone was measured without extraction, using an antiserum raised
in rabbits against a corticosterone-BSA conjugate and 125I-corticosterone-
BSA as tracer (MP Biomedicals). The sensitivity of the assay was 0.8 mg/dl;
intra- and inter-assay coefficients of variation were 5% and 10%, respectively.
PGE2 Assays
Tissue PGE2 levels were measured by enzyme immunoassay using reagents
in kit form (Prostaglandin E2 enzyme immunoassay kit-monoclonal; Cayman
Chemical Company). Details are given as Supplemental Experimental
Procedures.
Telemetry
Separate groups of rats received i.c.v. injections of control or Clod-Lips and
5 days later were implanted with jugular catheters for i.v. injection of IL-1,
LPS, or their respective vehicles, as described above. Under the same anes-
thetic dose, telemetry transmitters (Mini-Mitter) were implanted intra-abdom-
inally. Two days later, core body temperature and activity levels were recorded
continuously for 24 hr before and after i.v. injection. Transmitter output was
monitored by a receiver board beneath the animals’ cages, which recorded
core temperature (to ±0.1C) and episodes (counts) of gross horizontal
movement.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and Supplemental Experi-
mental Procedures and can be found with this article online at doi:10.1016/
j.neuron.2009.11.032.
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